> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Comments Sought on Developing CNS Stimulants
- URL: https://www.fdaweb.com/comments-sought-on-developing-cns-stimulants/
- Published: 2019-09-20T12:00:00.000Z
- Updated: 2026-09-15T01:51:24.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5145052

*Federal Register* notice: FDA is seeking comments on development and evaluation of abuse-deterrent formulations (ADFs) of central nervous system stimulants and whether such products could play a role in addressing public health concerns related to prescription stimulant misuse and abuse. The notice also provides an overview of available postmarket data on the use, misuse, and abuse of prescription stimulants and associated morbidity and mortality, along with similar data on prescription opioids to provide context; background information on the development and evaluation of ADF products; and specific questions on which FDA seeks input. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2019-09-20/pdf/2019-20372.pdf?ref=fdaweb.com).